IL193981A0 - Novel heterocyclic nf-kb inhibitors - Google Patents
Novel heterocyclic nf-kb inhibitorsInfo
- Publication number
- IL193981A0 IL193981A0 IL193981A IL19398108A IL193981A0 IL 193981 A0 IL193981 A0 IL 193981A0 IL 193981 A IL193981 A IL 193981A IL 19398108 A IL19398108 A IL 19398108A IL 193981 A0 IL193981 A0 IL 193981A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- novel heterocyclic
- heterocyclic
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/375,259 US7601745B2 (en) | 2004-09-27 | 2006-03-15 | Heterocyclic NF-kB inhibitors |
PCT/EP2006/002396 WO2007016979A2 (en) | 2005-07-29 | 2006-03-15 | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
PCT/EP2007/002265 WO2007104557A2 (en) | 2006-03-15 | 2007-03-14 | Novel heterocyclic nf-kb inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL193981A0 true IL193981A0 (en) | 2009-08-03 |
Family
ID=39869768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL193981A IL193981A0 (en) | 2006-03-15 | 2008-09-09 | Novel heterocyclic nf-kb inhibitors |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP2009529555A (es) |
KR (1) | KR20080104147A (es) |
AU (1) | AU2007224659A1 (es) |
BR (1) | BRPI0709595A2 (es) |
CA (1) | CA2646223A1 (es) |
EA (1) | EA200801838A1 (es) |
IL (1) | IL193981A0 (es) |
MX (1) | MX2008011696A (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009243812B2 (en) * | 2008-05-05 | 2014-06-05 | Merck Patent Gmbh | NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
US8716312B2 (en) * | 2008-11-19 | 2014-05-06 | Merck Sharp & Dohme Corporation | Inhibitors of diacylglycerol acyltransferase |
WO2013049407A2 (en) * | 2011-09-30 | 2013-04-04 | Kineta, Inc | Anti-viral compounds |
MX2015017512A (es) * | 2013-06-18 | 2016-06-30 | 4Sc Discovery Gmbh | Compuestos 2,3-dihidrobenzofuran-5-ilicos como inhibidores de cinasas dyrk. |
RS57533B1 (sr) * | 2014-01-29 | 2018-10-31 | Ucb Biopharma Sprl | Heteroaril amidi kao inhibitori proteinske agregacije |
KR101693035B1 (ko) | 2015-01-14 | 2017-01-06 | 충북대학교 산학협력단 | 1,2,3,4-테트라하이드로퀴놀린-2-카르복실산 n-(치환)페닐아미드 유도체 및 이의 용도 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004067510A (ja) * | 1997-12-26 | 2004-03-04 | Mitsubishi Pharma Corp | 新規イミダゾール誘導体 |
WO2002064558A2 (en) * | 2001-02-14 | 2002-08-22 | Sankyo Company, Limited | Oxazole derivatives, their preparation and their use as cytokine inhibitors |
GB0230162D0 (en) * | 2002-12-24 | 2003-02-05 | Metris Therapeutics Ltd | Compounds useful in inhibiting angiogenesis |
FR2856685B1 (fr) * | 2003-06-25 | 2005-09-23 | Merck Sante Sas | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
WO2005079791A1 (en) * | 2004-02-12 | 2005-09-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders |
WO2006032322A1 (en) * | 2004-09-20 | 2006-03-30 | 4Sc Ag | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
UA97348C2 (en) * | 2005-07-29 | 2012-02-10 | 4Сц Аг | HETEROCYCLIC NF-kB INHIBITORS |
-
2007
- 2007-03-14 EA EA200801838A patent/EA200801838A1/ru unknown
- 2007-03-14 MX MX2008011696A patent/MX2008011696A/es active IP Right Grant
- 2007-03-14 JP JP2008558718A patent/JP2009529555A/ja active Pending
- 2007-03-14 CA CA002646223A patent/CA2646223A1/en not_active Abandoned
- 2007-03-14 AU AU2007224659A patent/AU2007224659A1/en not_active Abandoned
- 2007-03-14 BR BRPI0709595-3A patent/BRPI0709595A2/pt not_active IP Right Cessation
- 2007-03-14 KR KR1020087022353A patent/KR20080104147A/ko not_active Application Discontinuation
-
2008
- 2008-09-09 IL IL193981A patent/IL193981A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009529555A (ja) | 2009-08-20 |
CA2646223A1 (en) | 2007-09-20 |
KR20080104147A (ko) | 2008-12-01 |
EA200801838A1 (ru) | 2009-02-27 |
BRPI0709595A2 (pt) | 2011-07-19 |
AU2007224659A1 (en) | 2007-09-20 |
MX2008011696A (es) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2402319T3 (pl) | Inhibitory DGAT | |
GB0619753D0 (en) | Enzyme inhibitors | |
HK1176601A1 (zh) | 抑制劑 | |
ZA200802585B (en) | Pyridopyrimidinone inhibitors of Pl3Kα | |
IL190292A0 (en) | PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka | |
PL2361922T3 (pl) | Produkty pośrednie do wytwarzania inhibitorów nukleozydowych HCV | |
IL189112A0 (en) | NOVEL HETEROCYCLIC NF-kB INHIBITORS | |
ZA200901073B (en) | Kinase inhibitor | |
IL194339A0 (en) | Enzyme inhibitors | |
PL2383271T3 (pl) | Aminochinolony jako inhibitory GSK-3 | |
HRP20130144T1 (en) | Renin inhibitors | |
IL198014A0 (en) | Heterocyclic derived metalloprotease inhibitors | |
IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
AP2009004784A0 (en) | Matrix metallproteinase inhibitors | |
IL193981A0 (en) | Novel heterocyclic nf-kb inhibitors | |
GB0608844D0 (en) | Enzyme inhibitors | |
GB0617161D0 (en) | Enzyme inhibitors | |
EP2222662A4 (en) | INHIBITORS OF KYNURENINE AMINO TRANSFERASE | |
IL197981A0 (en) | Kinase inhibitors | |
IL196187A0 (en) | NF-kB INHIBITOR | |
GB0516967D0 (en) | Inhibitors | |
GB0714941D0 (en) | Inhibitors | |
GB0713152D0 (en) | Phosphodlesterase inhibitors | |
GB0624958D0 (en) | Enzyme inhibitors | |
GB0612544D0 (en) | Enzyme inhibitors |